Defendant

A fails to pay the above fine.

No medical person, etc. shall receive money, goods, benefits, labor, entertainment, or other economic benefits provided for the purpose of sales promotion, such as inducing the adoption of drugs by a person, etc. who has obtained marketing approval under the Pharmaceutical Affairs Act.

1. Defendant A is an intention to operate the “S internal council member” in the Gyeonggi-si R.

Defendant

A receives a proposal from T and U to provide economic benefits, such as cash, upon prescribing special prescription drugs, such as pentlls, which are produced and sold in the malking, and to comply with it. On June 201, A received 6 million won in cash from T from the above member's clinic at around the above member's clinic's clinic at around 201, and received 1,4210,000 won in total by January 22, 2014, as in the list of crimes in attached Form A (Defendant A).

As a result, Defendant A received cash of KRW 1,4210,00 provided for the purpose of promoting sales such as inducing the adoption of medicines.

2. Defendant B is an intention to operate the “in-W” in Article 301 of the V Building at the time of the Gyeonggi-si.

Defendant

B Upon receipt of a proposal to the effect that “to provide economic benefits, such as cash, by prescribing prescription drugs, such as pentlls, which are produced and sold in Pakistan,” from Te. Around December 2010, B received 6.9 million won in cash from Te. Around December 2010, and received 26 times in total from May 2014, as in the list of crimes in the attached Form (Defendant B).

As a result, Defendant B received cash of KRW 30.6 million provided for the purpose of sales promotion, such as adoption of drugs and inducement for treatment.

3. Defendant C is an intention to operate the “Yaman” located in the Yaman-gu X in Gyeonggi-gu, Gyeonggi-do.

Defendant

C It is the pension panel that is produced and sold in the sowing sector from T by the sowing business employee.